You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glomerulonephritis

Showing 1 - 25 of 759
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

C3 Dominant Glomerulonephritis Among Egyptian Population

Recruiting
  • C3 Nephropathy
    • Sohag, Egypt
      Sohag university , faculty of medicine
    Nov 10, 2023

    C3G, IC-MPGN, C3 Glomerulopathy Trial (Pegcetacoplan)

    Not yet recruiting
    • C3G
    • +11 more
    • (no location specified)
    Apr 13, 2023

    A Study of Rituximab in Frontline Therapy for Glomerulonephritis

    Recruiting
    • Glomerulonephritis
      • Shanghai, China
      • +4 more
      Feb 27, 2023

      Urinary Biomarker in Membranous Glomerulonephritis

      Not yet recruiting
      • Membranous Nephropathy
      • urinary markers
      • (no location specified)
      Jan 18, 2023

      Anti-glomerular Basement Membrane Glomerulonephritis Trial in Groningen (Immunoadsorption (Immunosorba))

      Completed
      • Anti-glomerular Basement Membrane Glomerulonephritis
      • Immunoadsorption (Immunosorba)
      • Groningen, Gromiongen, Netherlands
        University Medical Center Groningen
      Nov 6, 2022

      Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)

      Not yet recruiting
      • Proliferative Glomerulonephritis With Monoclonal IgG Deposits
      • Rochester, Minnesota
        Mayo Clinic Minnesota
      Dec 8, 2022

      Hyperspectral Imaging in the Diagnosis of Glomerular Diseases

      Not yet recruiting
      • Glomerulonephritis, IGA
      • +4 more
      • Microscopic hyperspectral imaging system
      • (no location specified)
      Mar 31, 2023

      Metabolic Associated Fatty Liver Disease and Biopsy Proved Cases

      Recruiting
      • Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
        • Asyut, Egypt
        • +1 more
        Nov 27, 2023

        Glomerulonephritis Rapidly Progressive Trial (ALE.F02, Rituximab, GlucoCorticoid)

        Not yet recruiting
        • Glomerulonephritis Rapidly Progressive
        • ALE.F02
        • +5 more
        • (no location specified)
        Sep 14, 2023

        IC-MPGN Trial (Placebo, iptacopan)

        Not yet recruiting
        • IC-MPGN
        • (no location specified)
        Feb 23, 2023

        ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis Trial (Pioglitazone (ACTOS®),

        Not yet recruiting
        • ANCA Associated Vasculitis
        • +2 more
        • Pioglitazone (ACTOS®)
        • Placebo of Pioglitazone
        • (no location specified)
        Jul 7, 2023

        Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis, Healthy Trial in Ranica (C3NEF assay)

        Not yet recruiting
        • Hemolytic-Uremic Syndrome
        • +2 more
        • C3NEF assay
        • Ranica, BG, Italy
          Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
        Aug 9, 2023

        Glomerulonephritis, IGA Trial in Besançon (Blood collection, Urine sample)

        Not yet recruiting
        • Glomerulonephritis, IGA
        • Blood collection
        • Urine sample
        • Besançon, France
          Centre Hospitalier Universitaire de Besançon
        Mar 17, 2023

        Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, Autosomal Dominant Polycystic Kidney Trial in

        Not yet recruiting
        • Atypical Hemolytic Uremic Syndrome
        • +3 more
        • Skin biopsy
        • Ranica, BG, Italy
          Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
        Aug 9, 2023

        Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

        Recruiting
        • Bortezomib
        • +5 more
        • Shanghai, Shanghai, China
          Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
        Oct 28, 2022

        Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)

        Recruiting
        • Nephrotic Syndrome
        • +4 more
        • Rituximab Infusion
        • Oral Cyclosporine
        • Bethesda, Maryland
        • +1 more
        Jan 25, 2023

        Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing

        Recruiting
        • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
        • ANCA-Associated Glomerulonephritis
        • Chongqing, Chongqing, China
          Children's Hospital of Chongqing Medical University
        Jul 23, 2023

        Glomerulonephritis, Proteinuria Trial in Cairo (Empagliflozin 25 MG, )

        Completed
        • Glomerulonephritis
        • Proteinuria
        • Empagliflozin 25 MG
        • placebo
        • Cairo, Egypt
          Cairo university hospitals
        Mar 7, 2022

        High Incidence of Thrombotic Events in Patients With MN and DKD

        Active, not recruiting
        • Glomerulonephritis, Membranous
        • +3 more
        • Grouping based on previous laboratory results, no intervention.
        • Jinan, Shandong, China
          Qianfoshan Hospital
        Dec 7, 2022

        Glomerulonephritis, IGA Trial (Prednisolone, Prednisolone plus Cyclophosphamide)

        Not yet recruiting
        • Glomerulonephritis, IGA
        • (no location specified)
        Aug 19, 2022

        C3G, IC-MPGN, C3 Glomerulopathy Trial in Worldwide (Pegcetacoplan, Placebo)

        Recruiting
        • C3G
        • +11 more
        • Birmingham, Alabama
        • +27 more
        Aug 4, 2022

        Urinary T Lymphocytes Predict Renal Flares in Inactive

        Completed
        • Glomerulonephritis Acute
        • Analysis of urine samples with flow cytometry
        • Berlin, Germany
        • +1 more
        Mar 8, 2022

        Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

        Recruiting
        • Adenine Phosphoribosyltransferase Deficiency
        • +83 more
          • Bristol, South West, United Kingdom
            Zoe Plummer
          Sep 26, 2023

          Glomerulonephritis, Membranous, Nephrotic Syndrome,Idiopathic Trial in Japan (Rituximab (genetical recombination), Placebo)

          Not yet recruiting
          • Glomerulonephritis, Membranous
          • Nephrotic Syndrome，Idiopathic
          • Rituximab (genetical recombination)
          • Placebo
          • Anjo, Aichi, Japan
          • +7 more
          Jun 13, 2023

          Lupus Nephritis, Immunoglobulin A Nephropathy, Membranous Nephropathy Trial (povetacicept)

          Not yet recruiting
          • Lupus Nephritis
          • +2 more
          • (no location specified)
          Feb 16, 2023